Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder.
Dyskinesias are known to occur in many patients with Parkinson's disease treated with dopaminergic drugs but to date, drug-induced dyskinesias have not been observed in humans with no underlying basal ganglia disorder. We describe a patient with psychogenic parkinsonism and intravenous apomorphine abuse leading to subsequent choreatiform dyskinesias.
Happe
Svenja
S
Department of Clinical Neurophysiology, University of Göttingen, Germany. shappe@gwdg.de
Sommer
Martin
M
Meller
Johannes
J
Trenkwalder
Claudia
C
Paulus
Walter
W
D000978:Antiparkinson Agents / Q000009:adverse effects*; D001058:Apomorphine / Q000009:adverse effects*; D001479:Basal Ganglia / Q000000981:diagnostic imaging / Q000473:pathology; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000178:diet therapy; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods
D000978:Antiparkinson Agents; D001058:Apomorphine